Brokerages Set Hinge Health Inc. (NYSE:HNGE) PT at $59.93

Shares of Hinge Health Inc. (NYSE:HNGE) have been given a consensus rating of “Moderate Buy” by the nineteen analysts that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $59.9333.

A number of brokerages recently issued reports on HNGE. Baird R W raised shares of Hinge Health to a “hold” rating in a report on Friday, September 5th. Stifel Nicolaus increased their price objective on Hinge Health from $63.00 to $66.00 and gave the stock a “buy” rating in a research report on Thursday, September 11th. Bank of America increased their price objective on Hinge Health from $42.00 to $64.00 and gave the company a “buy” rating in a research note on Wednesday, August 6th. Needham & Company LLC raised their price objective on Hinge Health from $47.00 to $59.00 and gave the stock a “buy” rating in a report on Wednesday, August 6th. Finally, JMP Securities raised their price objective on Hinge Health from $58.00 to $65.00 and gave the company a “market outperform” rating in a research note on Wednesday, August 6th.

Institutional Trading of Hinge Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in HNGE. Mirae Asset Global Investments Co. Ltd. acquired a new position in Hinge Health during the third quarter valued at $37,000. Montag A & Associates Inc. acquired a new position in Hinge Health during the 2nd quarter worth $41,000. SBI Securities Co. Ltd. acquired a new position in Hinge Health during the 2nd quarter valued at $48,000. Aster Capital Management DIFC Ltd bought a new stake in shares of Hinge Health during the third quarter valued at approximately $49,000. Finally, Jones Financial Companies Lllp raised its position in Hinge Health by 348.0% in the third quarter. Jones Financial Companies Lllp now owns 1,120 shares of the company’s stock worth $54,000 after purchasing an additional 870 shares in the last quarter.

Hinge Health Price Performance

NYSE:HNGE opened at $40.95 on Thursday. The firm has a 50-day simple moving average of $51.10. Hinge Health has a one year low of $33.42 and a one year high of $62.18.

Hinge Health (NYSE:HNGE) last issued its quarterly earnings results on Tuesday, November 4th. The company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.20) by $0.18. The business had revenue of $154.21 million during the quarter, compared to analyst estimates of $142.44 million. The company’s revenue was up 53.3% on a year-over-year basis. Hinge Health has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS.

Hinge Health announced that its Board of Directors has approved a stock repurchase plan on Wednesday, November 12th that permits the company to repurchase $250.00 million in outstanding shares. This repurchase authorization permits the company to reacquire up to 7.2% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s management believes its shares are undervalued.

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.